Simple "closed-circuit" group-specific immunoadsorption system for ABO-incompatible kidney transplants

Transfusion and Apheresis Science

Volumn 36, Issue 3, 2007, Pages 225-233

  Balint, Bela ^a,b   Pavlovic, Mirjana ^c   Jevtic, Miodrag ^b   Hrvacevic, Rajko ^b   Ignjatovic, Ljiljana ^b   Ostojic, Gordana ^b   Mijuskovic, Zoran ^b   Blagojevic, Radmila ^d   Trkuljic, Miroljub ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

^c FLORIDA ATLANTIC UNIVERSITY   (United States)

^d University Clinical Center   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; TACROLIMUS;

ADULT; ANTIBODY DETECTION; APHERESIS; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL ARTICLE; COST; FEMALE; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PATIENT MONITORING; PLASMAPHERESIS; RECIPIENT; SENSITIVITY AND SPECIFICITY; SPLENECTOMY;

ABO BLOOD-GROUP SYSTEM; ADULT; ANTIBODIES; ANTIGENS, CD20; BLOOD GROUP INCOMPATIBILITY; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSORBENT TECHNIQUES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PILOT PROJECTS;

EID: 34447626963     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2006.11.004     Document Type: Article

References (26)

1. Klein H.G., and Anstee D.J. Mollison's blood transfusion in clinical medicine. 11th ed. (2005), Blackwell Publishing Inc., Malden-Oxford-Carlton
2. Balint B., and The National Apheresis Group. Apheresis in donor and therapeutic settings: recruitments vs. possibilities - a multicenter study. Transfus Apher Sci 33 2 (2005) 229-237
3. Balint B., Radovic M., Malesevic M., Jovicic A., Stamatovic D., Ostojic G., et al. The rationale for therapeutic apheresis in the treatment of hematologic and immune-mediated neurologic disorders. Blood Banking Transf Med 1 2 (2003) 73-80
4. Sulowicz W., and Stompor T. Application of LDL-apheresis and immunoadsorption in kidney diseases. Rocz Akad Med Bialymst 49 (2004) 127-134
5. Visvardis G., Manou E., Griveas I., Meimaridou D., Mitsopoulos E., Kyriklidou P., et al. Therapeutic apheresis of immune diseases in nephrology department. Renal Failure 26 5 (2004) 569-574
6. Otto C., Geiss H.C., Empen K., and Parhofer K.G. Long-term reduction of C-reactive protein concentration by regular LDL-apheresis. Atherosclerosis 174 1 (2004) 151-156
7. Matoba Y., Okubo H., and Nose Y. Therapeutic left ventricular assist device and apheresis on dilated cardiomyopathy. Artif Organs 28 2 (2004) 171-181
8. Stummvoll G.H., Aringer M., Jansen M., Smolen J.S., Derfler K., and Graninger W.B. Immunoadsorption (IAS) as a rescue therapy in SLE: considerations on safety and efficacy. Wien Klin Wochenschr 116 21-22 (2004) 716-724
9. Mahmoud K., Sobh M., El-Shenawy F., Mostafa A., Abo El Magd M., Hassan N., et al. Effect of high-dose intravenous immunoglobulin on suppression of alloantibodies against HLA in highly sensitized transplant candidates. Transplant Proc 36 6 (2004) 1850-1852
10. Ullrich H., and Kuehnl P. New trends in specific immunoadsorption. Transfus Apher Sci 30 3 (2004) 223-231
11. Nydegger U.E., Rieben R., Carrel T., and Mohacsi P. Solid organ transplantation across the ABO histo-blood group barrier: a case report. Transplant Proc 36 5 (2004) 1554-1557
12. Shishido S., Asanuma H., Tajima E., Hoshinaga K., Ogawa O., Hasegawa A., et al. ABO-incompatible living-donor kidney transplantation in children. Transplantation 74 2 (2002) 284-285
13. Warren D.S., Zachary A.A., Sonnenday C.J., King K.E., Cooper M., Ratner L.E., et al. Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am J Transplant 4 4 (2004) 561-568
14. Sawada T., Fuchinoue S., Kawase T., Kubota K., and Teraoka S. Preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy and DFPP-enabled non-responders to undergo ABO-incompatible kidney transplantation. Clin Transplant 18 3 (2004) 254-260
15. Donauer J., Wilpert J., Geyer M., Schwertfeger E., Kirste G., Drognitz O., et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience. Xenotransplantation 13 2 (2006) 108-110
16. Mazid M.A., and Kaplan M. An improved affinity support and immunoadsorbent with a synthetic blood group oligosaccharide and polymer coating for hemoperfusion. J Appl Biomater 3 1 (1992) 9-15
17. Shimmura H., Tanabe K., Ishikawa N., Tokumoto T., Fuchinoue S., Takahashi K., et al. Removal of anti-A/B antibodies with plasmapheresis in ABO-incompatible kidney transplantation. Ther Apher 4 5 (2000) 395-398
18. Kaihara S., Okamoto M., Akioka K., Ogino S., Higuchi A., Kadotani Y., et al. Improved graft survival in ABO-incompatible living donor kidney transplantation. Transplant Proc 37 4 (2005) 1804-1805
19. Lasky L.C., Warkentin P.I., Kersey J.H., Ramsay N.K., McGlave P.B., and McCullough J. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation. Transfusion 23 4 (1983) 277-285
20. Balint B., Radovic M., Taseski J., and Calija B. Investigation of the hydrosoluble type group-specific ABH and Lewis supstances. Acta Antropol Yugoslav 23 1 (1986) 5-12
21. Tyden G., Kumlien G., Genberg H., Sandberg J., Lundgren T., and Fehrman I. ABO-incompatible kidney transplantation and rituximab. Transplant Proc 37 8 (2005) 3286-3287
22. Melcher M.L., Olson J.L., Baxter-Lowe L.A., Stock P.G., and Posselt A.M. Antibody-mediated rejection of a pancreas allograft. Am J Transplant 6 2 (2006) 423-428
23. Jordan S.C., Vo A.A., Tyan D., Nast C.C., and Toyoda M. Current approaches to treatment of antibody-mediated rejection. Pediatr Transplant 9 3 (2005) 408-415
24. Segev D.L., Simpkins C.E., Warren D.S., King K.E., Shirey R.S., Maley W.R., et al. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 5 10 (2005) 2570-2575
25. Tyden G., Kumlien G., Genberg H., Sandberg J., Lundgren T., and Fehrman I. ABO-incompatible kidney transplantation without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 5 1 (2005) 145-148
26. Rydberg L., and Samuelsson B.E. Presence of glycosyltransferase inhibitors in the sera of patients with long-term surviving ABO incompatible (A2 to O) kidney grafts. Transfus Med 1 (1991) 177-178